Beam Therapeutics (BEAM) Earnings Date & Reports

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BEAM is expected to report earnings to fall 2.54% to -114 cents per share on November 09

Beam Therapeutics BEAM Stock Earnings Reports

Q3'26

Est.

$-1.15

Q2'26

Missed

by $0.08

Q1'26

Beat

by $0.12

Q4'25

Beat

by $3.34

Q3'25

Missed

by $0.05

The last earnings report on August 04 showed earnings per share of -117 cents, missing the estimate of -110 cents. With 874.12K shares outstanding, the current market capitalization sits at 2.50B.

View a ticker or compare two or three

BEAM

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for BEAM